Case Report
Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis
Figure 1
Timeline with the estimated glomerular filtration rate (eGFR) and diameters of target lymph nodal metastases.